Protagenic Therapeutics Inc (NASDAQ:PTIX) currently has a daily average trading volume of 362.62K but it saw 3971021 shares traded in last market. With a market cap of 2.72M USD, the company’s current market price of $0.37 came rising about 11.82 while comparing to the previous closing price of $0.34. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.87 and as low as $0.34. In the recent trading on the day, stock has struck highest price mark of $0.325 while lowest mark touched by it was $0.378.
Taking a look at 20-day trading activity of Protagenic Therapeutics Inc (PTIX) gives us an average price of $0.4395, while its current price level is -79.97% below from 52-week high level whereas it is 11.82% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5117 while that of 200 days or SMA-200 reads an average of $0.7773. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.76% during that period while stretching the period over a month that decreases to 13.62%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 40.51 which implies that the stock is in neutral territory.
Over the week, PTIX’s stock price is moving -10.43% down while it is -25.97% when we observe its performance for the past one month. Year-to-date it is -23.55% down and over the past year, the stock is showing a downside performance of -56.94%.
Currently, Protagenic Therapeutics Inc’s total number of outstanding shares is 7.24M. Company’s return on investment (ROI) stands at -785.50% and return on equity (ROE) at -231.87%. Stock has a price to book (P/B) ratio of 2.50. Its return on asset (ROA) is -162.74% on average.
